Bertille Campion

Baseline <scp>ALBI</scp> score and early variation of serum <scp>AFP</scp> predicts outcomes in patients with <scp>HCC</scp> treated by atezolizumab–bevacizumab

Claudia Campani, Jessica Bamba‐Funck, Bertille Campion et al. · Liver International · 2022 · 47 citations

A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with <scp>HCC</scp>

Edouard Larrey, Bertille Campion, Manon Evain et al. · Liver International · 2022 · 32 citations

Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma

Manon Allaire, Bertille Campion, Alix Demory et al. · Alimentary Pharmacology & Therapeutics · 2023 · 32 citations

Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab

Philippe Sultanik, Claudia Campani, Edouard Larrey et al. · Digestive and Liver Disease · 2024 · 15 citations